Clinical Trial Update: Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial comparing dose-escalated photon IMRT or proton beam radiation therapy with standard-dose radiation therapy plus temozolomide in newly diagnosed gl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: NRG Oncology | Conditions: Glioblastoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING